Business & Corporate Information Services
  • About Us
  • Services
  • Industries
  • Clients
  • Team
  • Resource Center
  • Career
Contact Us
October 3, 2024in

RIV Capital Appoints David E Vautrin to Interim CEO

Post navigation

Previous post

Apriori Bio Appoints Harry Kleanthous, Ph.D., as Chief Scientific Officer

Next post

Spyre Therapeutics Appoints Dr. Sheldon Sloan as Chief Medical Officer

Recent Posts

    Recent Comments

    No comments to show.

    Archives

    No archives to show.

    Categories

    • No categories